Association of CaN/NFAT neuroinflammatory pathway with cognitive impairment and depression in Type 2 diabetes mellitus patients

Chronic T2DM is often association various other complications such as atherosclerosis, obesity, hypertension and neuropsychiatric disorders such as mild cognitive impairment that can progress to dementia or Alzheimer’s and depression. My study involves assessment of T2DM patients and prediction of early biomarkers for the assessment of mild cognitive impairment and depression in such patients. Early assessment of mild cognitive impairment and depression in such patients will allow early intervention and development of personalized treatment plan for these patients in order to combat future prognosis of these abnormalities. Early intervention and care will provide a better quality of life and decreased risk of future complications associated with chronic T2DM.